Phase 3 Readout~month

Phase 3 Topline: A Phase 3 Randomized, Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Golim

Indication
Colitis, Ulcerative

Other upcoming events for GHRS

Phase 2 StartPhase 2 Start: A Phase 1/2 Open-Label Intrathecal Administration of TSHA-105 to Determine the Safety and Efficacy i
Phase 2 StartPhase 2 Start: Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled
Phase 2 StartPhase 2 Start: MOZART MZL: A Randomized Phase II Study Evaluating Mosunetuzumab Alone and in Combination With Eithe
Phase 2 StartPhase 2 Start: A Phase II Randomized Study of Blinatumomab With or Without Revumenib for Patients With KMT2A-Transl
Phase 1 StartPhase 1 Start: A Phase I Evaluation of the Safety and Tolerability of Pirfenidone in Idiopathic Subglottic Stenosis

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3 Randomized, Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Golim — GHRS Phase 3 Readout | BioSniper